Can I switch from semaglutide to tirzepatide?

Yes. Start tirzepatide at 2.5 mg and titrate up. Most providers recommend a 1-2 week washout period. Always consult your provider.

Why do people switch from semaglutide to tirzepatide?

Weight loss plateau, inadequate response, side effects, insurance changes, or wanting tirzepatide's superior efficacy (~20.9% vs ~14.9%).

Is there a dose conversion between semaglutide and tirzepatide?

No. They are different molecules. Start tirzepatide at 2.5 mg and follow standard titration.

Will I gain weight when switching?

Most patients do not gain weight, but weight loss may slow temporarily during titration. Once at 5 mg+, weight loss typically resumes and often exceeds semaglutide results.

What side effects should I expect when switching?

Nausea, fatigue, or GI side effects may recur for 2-4 weeks. Starting at 2.5 mg minimizes this. Patients who tolerated semaglutide generally tolerate tirzepatide.

Can I switch from semaglutide to tirzepatide?

Yes, switching from semaglutide to tirzepatide is possible and increasingly common. You cannot convert doses directly — you must start tirzepatide at the lowest dose (2.5 mg) and titrate up. Always consult your provider before switching. Most providers recommend a 1-2 week washout period between medications.

Why do people switch from semaglutide to tirzepatide?

The most common reasons are: weight loss plateau on semaglutide, inadequate response (less than 5% weight loss in 3 months), intolerable side effects, insurance coverage changes, or wanting tirzepatide's superior efficacy (~20.9% vs ~14.9% weight loss). The SURMOUNT-5 trial confirmed tirzepatide produces more weight loss head-to-head.

Is there a dose conversion between semaglutide and tirzepatide?

No. Semaglutide and tirzepatide are different molecules with different mechanisms. There is no direct dose conversion. When switching, you start tirzepatide at 2.5 mg weekly and follow the standard titration schedule (increase by 2.5 mg every 4 weeks as tolerated).

Will I gain weight when switching from semaglutide to tirzepatide?

Most patients do not gain weight during the transition, but weight loss may slow temporarily while titrating to a therapeutic tirzepatide dose. Some patients experience a brief plateau during weeks 1-4 of tirzepatide as the dose builds up. Once at 5 mg or higher, weight loss typically resumes and often exceeds what was achieved on semaglutide.

What side effects should I expect when switching?

You may experience a recurrence of nausea, fatigue, or GI side effects during the first 2-4 weeks of tirzepatide, similar to when you first started semaglutide. Starting at the lowest dose (2.5 mg) minimizes this. Patients who tolerated semaglutide well generally tolerate tirzepatide, though nausea can be slightly more pronounced with tirzepatide at higher doses.

Switching from Semaglutide to Tirzepatide: What You Need to Know

Why switch from semaglutide to tirzepatide?

Semaglutide (Wegovy, Ozempic) has helped millions lose weight, but a significant number of patients experience a weight loss plateau, inadequate response, or intolerable side effects. The SURMOUNT-5 trial (NEJM 2025) confirmed that tirzepatide (Zepbound, Mounjaro) produces significantly more weight loss than semaglutide in a head-to-head comparison — ~20.9% vs ~14.9% of body weight.

Common reasons for switching:

Weight loss plateau after initial success on semaglutide
Inadequate response — less than 5% weight loss in 3 months
Desire for maximum efficacy — tirzepatide's dual GIP/GLP-1 mechanism produces superior results
Side effect intolerance — some patients tolerate tirzepatide better
Insurance or cost changes — LillyDirect vials may be cheaper than Wegovy
New indication — Zepbound is now also approved for obstructive sleep apnea

How the switch works

There is no direct dose conversion between semaglutide and tirzepatide. They are different molecules with different mechanisms. The standard switching protocol:

Stop semaglutide. Take your last semaglutide dose as scheduled, then stop.
Washout period (1–2 weeks). Most providers recommend waiting 1–2 weeks to let semaglutide clear your system. Semaglutide has a half-life of ~1 week, so 2 weeks allows ~2 half-lives.
Start tirzepatide at 2.5 mg. This is the lowest starting dose, regardless of what dose of semaglutide you were on.
Titrate every 4 weeks. Increase by 2.5 mg every 4 weeks as tolerated: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg.
Monitor side effects. You may experience a recurrence of nausea or GI symptoms during the first 2–4 weeks, similar to when you first started semaglutide.

What results to expect after switching

Timeframe	What to expect
Weeks 1–4 (2.5 mg)	Appetite suppression returns. Possible mild nausea. Weight loss may be slow as dose builds.
Weeks 4–8 (5 mg)	Weight loss typically resumes. Many patients see a "second wind" of weight loss.
Weeks 8–16 (7.5–10 mg)	Significant weight loss. Patients who plateaued on semaglutide often see 5–10% additional loss.
Weeks 16–24 (10–15 mg)	Maximum efficacy. Total weight loss from both medications may reach 20–25% of body weight.

Will I gain weight during the transition?

Most patients do not gain weight during the switch, but weight loss may slow temporarily while titrating to a therapeutic tirzepatide dose. The 2.5 mg starting dose is subtherapeutic for most adults, so appetite suppression may be weaker during weeks 1–4 compared to your maintenance semaglutide dose. Once you reach 5 mg or higher, weight loss typically resumes and often exceeds what you achieved on semaglutide.

To minimize weight regain risk during the transition:

Maintain your dietary habits from semaglutide (protein, small meals)
Continue regular exercise, especially resistance training
Track your weight weekly and report any significant gain to your provider
Avoid "catch-up eating" during the washout period

Side effects when switching

You may experience a recurrence of side effects similar to when you first started semaglutide:

Nausea — most common, especially at dose increases. May be slightly more pronounced with tirzepatide.
Fatigue — usually resolves within 2–4 weeks.
GI changes — diarrhea or constipation may shift.
Injection site reactions — tirzepatide uses a different pen device; rotate sites.

Patients who tolerated semaglutide well generally tolerate tirzepatide, though individual responses vary. If side effects are severe at any dose, contact your provider — they may slow the titration schedule.

See our complete GLP-1 side effects guide for management strategies.

Thinking about switching GLP-1 medications?

A US-licensed provider can help you decide if tirzepatide is right for you.

Consult a provider

Cost comparison after switching

Option	Monthly cost	Notes
Zepbound (LillyDirect vials)	$299–$449	Cheapest brand-name tirzepatide without insurance
Zepbound (with insurance)	$25–$50 copay	With savings card and commercial insurance
Compounded tirzepatide (telehealth)	$249–$449	Not FDA-approved; via licensed compounding pharmacy
Wegovy (for comparison)	$149–$1,300	NovoCare pen vs retail price

See our GLP-1 Cost Guide 2026 for a complete pricing breakdown.

Related guides

Medical disclaimer: This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before switching medications.

Switching from Semaglutide to Tirzepatide: Complete Guide

Start your GLP-1 weight-loss plan today